Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.87

€0.87

-4.400%
-0.04
-4.400%
-
 
30.04.24 / Stuttgart Stock Exchange WKN: A3C9JV / Name: Bionomics Ltd. / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Bionomics Ltd. Stock

Heavy losses for Bionomics Ltd. today as the stock fell by -€0.040 (-4.400%).
Our community identified positive and negative aspects for Bionomics Ltd. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Bionomics Ltd. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Bionomics Ltd. in the next few years

Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-10-30

Imagine stepping into an artist's studio. The chaotic beauty of the unfinished work may not make sense at first, but as you peer deeper, patterns emerge. This is akin to unravelling the financials of a company like Bionomics Ltd. At an initial glimpse, it appears that the company is in a challenging circumstance. Continuing with this analogy, the company is currently working on its masterpiece - its portfolio.

The financial health of Bionomics Ltd., a stalwart in the industry, mirrors its mettle in the fiercely competitive landscape. However, there are overtones of risk mixed with potential, similar to an adventurer navigating a labyrinth, looking for treasure. Let's delve deeper into the financial parameters that illustrate this picture in more detail.

1. Market Capitalisation: